These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21818350)

  • 41. Intradermal and virosomal influenza vaccines for preventing influenza hospitalization in the elderly during the 2011-2012 influenza season: a comparative effectiveness study using the Valencia health care information system.
    Puig-Barberà J; Natividad-Sancho A; Calabuig-Pérez J; Lluch-Rodrigo JA; Pastor-Villalba E; Martínez-Úbeda S; Díez-Domingo J
    Vaccine; 2014 Sep; 32(42):5447-54. PubMed ID: 25131737
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019.
    Mouratidou E; Lambrou A; Andreopoulou A; Gioula G; Exindari M; Kossyvakis A; Pogka V; Mentis A; Georgakopoulou T; Lytras T
    Vaccine; 2020 Mar; 38(12):2715-2724. PubMed ID: 32033848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort.
    Kwong JC; Buchan SA; Chung H; Campitelli MA; Schwartz KL; Crowcroft NS; Jackson ML; Karnauchow T; Katz K; McGeer AJ; McNally JD; Richardson DC; Richardson SE; Rosella LC; Simor A; Smieja M; Zahariadis G; Campigotto A; Gubbay JB
    Vaccine; 2019 Jul; 37(31):4392-4400. PubMed ID: 31221563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.
    Rondy M; Launay O; Puig-Barberà J; Gefenaite G; Castilla J; de Gaetano Donati K; Galtier F; Hak E; Guevara M; Costanzo S; ; Moren A
    Euro Surveill; 2015 Jan; 20(2):. PubMed ID: 25613779
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.
    Nichol KL; Margolis KL; Wuorenma J; Von Sternberg T
    N Engl J Med; 1994 Sep; 331(12):778-84. PubMed ID: 8065407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly.
    Darvishian M; Gefenaite G; Turner RM; Pechlivanoglou P; Van der Hoek W; Van den Heuvel ER; Hak E
    J Clin Epidemiol; 2014 Jul; 67(7):734-44. PubMed ID: 24768004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review.
    Remschmidt C; Wichmann O; Harder T
    BMC Infect Dis; 2015 Oct; 15():429. PubMed ID: 26474974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influenza vaccine effectiveness against hospitalization during the 2018/2019 season among older persons aged ≥ 75 years in Japan: The LIFE-VENUS Study.
    Mimura W; Ishiguro C; Fukuda H
    Vaccine; 2022 Aug; 40(34):5023-5029. PubMed ID: 35851488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic.
    Jackson ML; Yu O; Nelson JC; Naleway A; Belongia EA; Baxter R; Narwaney K; Jacobsen SJ; Shay DK; Jackson LA
    Am J Epidemiol; 2013 Oct; 178(8):1327-36. PubMed ID: 23978527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bias in the measure of the effectiveness of seasonal influenza vaccination among diabetics.
    Casanova L; Gobin N; Villani P; Verger P
    Prim Care Diabetes; 2016 Dec; 10(6):398-406. PubMed ID: 27290610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is the adjuvanted influenza vaccine more effective than the trivalent inactivated vaccine in the elderly population? Results of a case-control study.
    Spadea A; Unim B; Colamesta V; Meneghini A; D'Amici AM; Giudiceandrea B; La Torre G
    Vaccine; 2014 Sep; 32(41):5290-4. PubMed ID: 25087677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative effectiveness of high-dose versus standard-dose influenza vaccination in community-dwelling veterans.
    Richardson DM; Medvedeva EL; Roberts CB; Linkin DR;
    Clin Infect Dis; 2015 Jul; 61(2):171-6. PubMed ID: 25829001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intraseason decline in influenza vaccine effectiveness during the 2016 southern hemisphere influenza season: A test-negative design study and phylogenetic assessment.
    Regan AK; Fielding JE; Chilver MB; Carville KS; Minney-Smith CA; Grant KA; Thomson C; Hahesy T; Deng YM; Stocks N; Sullivan SG
    Vaccine; 2019 May; 37(19):2634-2641. PubMed ID: 30952499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017-18 influenza season.
    Divino V; Krishnarajah G; Pelton SI; Mould-Quevedo J; Anupindi VR; DeKoven M; Postma MJ
    Vaccine; 2020 Sep; 38(40):6334-6343. PubMed ID: 32739119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.
    Johns MC; Eick AA; Blazes DL; Lee SE; Perdue CL; Lipnick R; Vest KG; Russell KL; DeFraites RF; Sanchez JL
    PLoS One; 2010 May; 5(5):e10722. PubMed ID: 20502705
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.
    Rondy M; Launay O; Castilla J; Costanzo S; Puig-Barberà J; Gefenaite G; Larrauri A; Rizzo C; Pitigoi D; Syrjänen RK; Machado A; Kurečić Filipović S; Krisztina Horváth J; Paradowska-Stankiewicz I; Marbus S; ; Moren A
    Vaccine; 2017 Aug; 35(34):4298-4306. PubMed ID: 28709555
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2002-2005 influenza periods.
    Vila-Córcoles A; Rodriguez T; de Diego C; Ochoa O; Valdivieso A; Salsench E; Ansa X; Badía W; Saún N;
    Vaccine; 2007 Sep; 25(37-38):6699-707. PubMed ID: 17698263
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inactivated influenza vaccine effectiveness and an analysis of repeated vaccination for children during the 2016/17 season.
    Shinjoh M; Sugaya N; Yamaguchi Y; Iibuchi N; Kamimaki I; Goto A; Kobayashi H; Kobayashi Y; Shibata M; Tamaoka S; Nakata Y; Narabayashi A; Nishida M; Hirano Y; Munenaga T; Morita K; Mitamura K; Takahashi T;
    Vaccine; 2018 Sep; 36(37):5510-5518. PubMed ID: 30093289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of local influenza vaccine effectiveness using two methods.
    Balasubramani GK; Zimmerman RK; Eng H; Lyons J; Clarke L; Nowalk MP
    Vaccine; 2021 Feb; 39(8):1283-1289. PubMed ID: 33485643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
    J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.